Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

35.08 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 260
Open 35.08
Bid (Size) 34.59 (2)
Ask (Size) 34.92 (2)
Prev. Close 35.08
Today's Range 35.08 - 35.08
52wk Range 27.34 - 59.62
Shares Outstanding 308,456,852
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
From Legend Biotech USA Inc.
Via GlobeNewswire

Performance

YTD
+1.0%
+1.0%
1 Month
-15.5%
-15.5%
3 Month
+22.0%
+22.0%
6 Month
-5.2%
-5.2%
1 Year
-38.1%
-38.1%

More News

Read More
The Analyst Verdict: Legend Biotech In The Eyes Of 5 Experts
Via Benzinga
Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
Via MarketMinute
Topics Economy Stocks
Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q2 2025 Earnings with Revenue Beat and EPS Miss Amid Strong CARVYKTI Sales
Via Chartmill
Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
Earnings Outlook For Legend Biotech
Via Benzinga
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
Looking Into Legend Biotech's Recent Short Interest
Via Benzinga
Is Legend Biotech Gaining or Losing Market Support?
Via Benzinga
What Does the Market Think About Legend Biotech?
Via Benzinga
Earnings Scheduled For August 11, 2025
Via Benzinga
A Glimpse Into The Expert Outlook On Legend Biotech Through 6 Analysts
Via Benzinga
The FDA Shake-Up Continues, And Could Impact Genetic Medicines
Via Investor's Business Daily
Topics Government
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday
Via Benzinga
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Monday
Via Benzinga
Earnings Scheduled For May 13, 2025
Via Benzinga
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst
Via Benzinga
Topics World Trade
5 Analysts Have This To Say About Legend Biotech
Via Benzinga

Frequently Asked Questions

Is Legend Biotech Corporation - American Depositary Shares publicly traded?
Yes, Legend Biotech Corporation - American Depositary Shares is publicly traded.
What exchange does Legend Biotech Corporation - American Depositary Shares trade on?
Legend Biotech Corporation - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Legend Biotech Corporation - American Depositary Shares?
The ticker symbol for Legend Biotech Corporation - American Depositary Shares is LEGN on the Nasdaq Stock Market
What is the current price of Legend Biotech Corporation - American Depositary Shares?
The current price of Legend Biotech Corporation - American Depositary Shares is 35.08
When was Legend Biotech Corporation - American Depositary Shares last traded?
The last trade of Legend Biotech Corporation - American Depositary Shares was at 08/26/25 04:00 PM ET
What is the market capitalization of Legend Biotech Corporation - American Depositary Shares?
The market capitalization of Legend Biotech Corporation - American Depositary Shares is 10.82B
How many shares of Legend Biotech Corporation - American Depositary Shares are outstanding?
Legend Biotech Corporation - American Depositary Shares has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.